VITAE Biomedical Co. Ltd. is a molecular screening technology company focused on innovation and leading, providing the most valuable molecular screening technology for cancer and other diseases. We hope to further apply the research results to clinical practice Medical diagnosis, in response to the current highly unmet medical needs for some cancer screening, proposes the best solution, and constructs a fast and accurate test module.

Recently, lung cancer can only be screened by X-ray and CT (LDCT), and depends on the experience of physicians. The screening module developed by VITAE Biomedical is the lung cancer test method that can be detected by biomolecular markers and is suitable for early Lung cancer Screening, greatly improving the survival rate of lung cancer patients. And the use of urine as the specimen is not only non-invasive, but also eliminates the radiation exposure problem of imaging diagnosis.